Limits to third-party reporting: Evidence from a randomized field experiment in Norway - ScienceDirect

€ 8.99

4.8
(311)
En stock
Descripción

Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study - The

Phytosterol supplementation in capsules or tablets as adjunctive treatment for hypercholesterolemia: A systematic review of randomized controlled trials - Clinical Nutrition ESPEN

Evidence of households' demand flexibility in response to variable hourly electricity prices – Results from a comprehensive field experiment in Norway - ScienceDirect

European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission - The Lancet Oncology

Navigating the information pathway to carbon capture and storage acceptance: Patterns and insights from a literature review - ScienceDirect

Associations of PTEN and ERG with Magnetic Resonance Imaging Visibility and Assessment of Non–organ-confined Pathology and Biochemical Recurrence After Radical Prostatectomy - European Urology Focus

IJERPH, Free Full-Text

Limits to third-party reporting: Evidence from a randomized field experiment in Norway - ScienceDirect

The OARSI Joint Effort Initiative: Priorities for osteoarthritis management program implementation and research 2024–2028 - Osteoarthritis and Cartilage Open

Long-term changes in nutritional status and body composition in patients with malignant pancreatic disease - A systematic review - Clinical Nutrition ESPEN

A scoping review of personalized user experiences on social media: The interplay between algorithms and human factors - ScienceDirect

Salmon Food-Specific Compounds and Their Metabolites Increase in Human Plasma and Are Associated with Cardiometabolic Health Indicators Following a Mediterranean-Style Diet Intervention - The Journal of Nutrition